Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Observational Study Design to Determine the Sensitivity of the UroMark Assay, a Urine Test, to Detect New and Recurrent Low, Intermediate and High Grade Bladder Cancer

NCT02781428 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02781428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02781428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Observational Study Design to Determine the Sensitivity of the UroMark Assay, a Urine Test, to Detect New and Recurrent Low, Intermediate and High Grade Bladder Cancer
Lead sponsor
University College, London
Phase
Observational
Overall status
Completed
Start date
September 26, 2016
Completion date
December 19, 2018
Enrollment
1,643 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer